Cargando…

Development of an Improved 3D in vitro Intestinal Model to Perform Permeability Studies of Paracellular Compounds

The small intestine is the primary site of drug absorption following oral administration, making paramount the proper monitoring of the absorption process. In vitro tools to predict intestinal absorption are particularly important in preclinical drug development since they are less laborious and cos...

Descripción completa

Detalles Bibliográficos
Autores principales: Macedo, Maria Helena, Martínez, Elena, Barrias, Cristina C., Sarmento, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527803/
https://www.ncbi.nlm.nih.gov/pubmed/33042961
http://dx.doi.org/10.3389/fbioe.2020.524018
_version_ 1783589135456403456
author Macedo, Maria Helena
Martínez, Elena
Barrias, Cristina C.
Sarmento, Bruno
author_facet Macedo, Maria Helena
Martínez, Elena
Barrias, Cristina C.
Sarmento, Bruno
author_sort Macedo, Maria Helena
collection PubMed
description The small intestine is the primary site of drug absorption following oral administration, making paramount the proper monitoring of the absorption process. In vitro tools to predict intestinal absorption are particularly important in preclinical drug development since they are less laborious and cost-intensive and raise less ethical considerations compared to in vivo studies. The Caco-2 model is considered the gold standard of in vitro intestinal models regarding the prediction of absorption of orally delivered compounds. However, this model presents several drawbacks, such as the expression of tighter tight junctions, not being suitable to perform permeability of paracellular compounds. Besides, cells are representative of only one intestinal cell type, without considering the role of non-absorptive cells on the absorption pathway of drugs. In the present study, we developed a new three-dimensional (3D) intestinal model that aims to bridge the gap between in vitro tools and animal studies. Our 3D model comprises a collagen layer with human intestinal fibroblasts (HIFs) embedded, mimicking the intestinal lamina propria and providing 3D support for the epithelium, composed of Caco-2 cells and mucus-producing HT29-MTX cells, creating a model that can better resemble, both in terms of composition and regarding the outcomes of drug permeability when testing paracellular compounds, the human small intestine. The optimization of the collagen layer with HIFs was performed, testing different collagen concentrations and HIF seeding densities in order to avoid collagen contraction before day 14, maintaining HIF metabolically active inside the collagen disks during time in culture. HIF morphology and extracellular matrix (ECM) deposition were assessed, confirming that fibroblasts presented a normal and healthy elongated shape and secreted fibronectin and laminin, remodeling the collagen matrix. Regarding the epithelial layer, transepithelial electrical resistance (TEER) values decreased when cells were in the 3D configuration, comparing with the 2D analogs (Caco-2 and coculture of Caco-2+HT29-MTX models), becoming more similar with in vivo values. The permeability assay with fluorescein isothiocyanate (FITC)–Dextran 4 kDa showed that absorption in the 3D models is significantly higher than that in the 2D models, confirming the importance of using a more biorelevant model when testing the paracellular permeability of compounds.
format Online
Article
Text
id pubmed-7527803
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-75278032020-10-09 Development of an Improved 3D in vitro Intestinal Model to Perform Permeability Studies of Paracellular Compounds Macedo, Maria Helena Martínez, Elena Barrias, Cristina C. Sarmento, Bruno Front Bioeng Biotechnol Bioengineering and Biotechnology The small intestine is the primary site of drug absorption following oral administration, making paramount the proper monitoring of the absorption process. In vitro tools to predict intestinal absorption are particularly important in preclinical drug development since they are less laborious and cost-intensive and raise less ethical considerations compared to in vivo studies. The Caco-2 model is considered the gold standard of in vitro intestinal models regarding the prediction of absorption of orally delivered compounds. However, this model presents several drawbacks, such as the expression of tighter tight junctions, not being suitable to perform permeability of paracellular compounds. Besides, cells are representative of only one intestinal cell type, without considering the role of non-absorptive cells on the absorption pathway of drugs. In the present study, we developed a new three-dimensional (3D) intestinal model that aims to bridge the gap between in vitro tools and animal studies. Our 3D model comprises a collagen layer with human intestinal fibroblasts (HIFs) embedded, mimicking the intestinal lamina propria and providing 3D support for the epithelium, composed of Caco-2 cells and mucus-producing HT29-MTX cells, creating a model that can better resemble, both in terms of composition and regarding the outcomes of drug permeability when testing paracellular compounds, the human small intestine. The optimization of the collagen layer with HIFs was performed, testing different collagen concentrations and HIF seeding densities in order to avoid collagen contraction before day 14, maintaining HIF metabolically active inside the collagen disks during time in culture. HIF morphology and extracellular matrix (ECM) deposition were assessed, confirming that fibroblasts presented a normal and healthy elongated shape and secreted fibronectin and laminin, remodeling the collagen matrix. Regarding the epithelial layer, transepithelial electrical resistance (TEER) values decreased when cells were in the 3D configuration, comparing with the 2D analogs (Caco-2 and coculture of Caco-2+HT29-MTX models), becoming more similar with in vivo values. The permeability assay with fluorescein isothiocyanate (FITC)–Dextran 4 kDa showed that absorption in the 3D models is significantly higher than that in the 2D models, confirming the importance of using a more biorelevant model when testing the paracellular permeability of compounds. Frontiers Media S.A. 2020-09-17 /pmc/articles/PMC7527803/ /pubmed/33042961 http://dx.doi.org/10.3389/fbioe.2020.524018 Text en Copyright © 2020 Macedo, Martínez, Barrias and Sarmento. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Macedo, Maria Helena
Martínez, Elena
Barrias, Cristina C.
Sarmento, Bruno
Development of an Improved 3D in vitro Intestinal Model to Perform Permeability Studies of Paracellular Compounds
title Development of an Improved 3D in vitro Intestinal Model to Perform Permeability Studies of Paracellular Compounds
title_full Development of an Improved 3D in vitro Intestinal Model to Perform Permeability Studies of Paracellular Compounds
title_fullStr Development of an Improved 3D in vitro Intestinal Model to Perform Permeability Studies of Paracellular Compounds
title_full_unstemmed Development of an Improved 3D in vitro Intestinal Model to Perform Permeability Studies of Paracellular Compounds
title_short Development of an Improved 3D in vitro Intestinal Model to Perform Permeability Studies of Paracellular Compounds
title_sort development of an improved 3d in vitro intestinal model to perform permeability studies of paracellular compounds
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527803/
https://www.ncbi.nlm.nih.gov/pubmed/33042961
http://dx.doi.org/10.3389/fbioe.2020.524018
work_keys_str_mv AT macedomariahelena developmentofanimproved3dinvitrointestinalmodeltoperformpermeabilitystudiesofparacellularcompounds
AT martinezelena developmentofanimproved3dinvitrointestinalmodeltoperformpermeabilitystudiesofparacellularcompounds
AT barriascristinac developmentofanimproved3dinvitrointestinalmodeltoperformpermeabilitystudiesofparacellularcompounds
AT sarmentobruno developmentofanimproved3dinvitrointestinalmodeltoperformpermeabilitystudiesofparacellularcompounds